NeoGenomics
NEO
$12.31
Share price
-0.40%
Change (1 day)
23.10%
Change (1 year)
NeoGenomics (NEO) - P/B ratio
P/B ratio as of September 2023 : 1.64
According to NeoGenomics
's latest financial reports the company has a price-to-book ratio of 1.64.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
NeoGenomics - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 1.17 | -69.15% |
| 2021-12-31 | 3.79 | -55.98% |
| 2020-12-31 | 8.61 | 42.54% |
| 2019-12-31 | 6.04 | 62.49% |
| 2018-12-31 | 3.72 | 7.25% |
| 2017-12-31 | 3.47 | -3.87% |
| 2016-12-31 | 3.61 | 43.89% |
| 2015-12-31 | 2.51 | -39.74% |
| 2014-12-31 | 4.16 | -49.22% |
| 2013-12-31 | 8.19 | -32.79% |
| 2012-12-31 | 12.2 | 18.71% |
| 2011-12-31 | 10.3 | -33.86% |
| 2010-12-31 | 15.5 | 57.01% |
| 2009-12-31 | 9.88 | -23.3% |
| 2008-12-31 | 12.9 | -11.73% |
| 2007-12-31 | 14.6 | -98.04% |
| 2006-12-31 | 745 | -17174.31% |
| 2005-12-31 | -4.36 | -65.45% |
| 2004-12-31 | -12.6 | 403.22% |
| 2003-12-31 | -2.51 | -101.63% |
| 2002-12-31 | 154 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 2.20 | 33.80% | 🇺🇸 USA |
 LabCorp LH | 2.07 | 26.03% | 🇺🇸 USA |
 RadNet RDNT | 2.48 | 50.93% | 🇺🇸 USA |
 Psychemedics PMD | 2.36 | 43.69% | 🇺🇸 USA |
 Enzo Biochem ENZ | 3.67 | 123.57% | 🇺🇸 USA |